- Trials with a EudraCT protocol (23)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
23 result(s) found for: Conventional Angiography.
Displaying page 1 of 2.
EudraCT Number: 2020-000449-15 | Sponsor Protocol Number: DIONYSIUS | Start Date*: 2020-12-11 |
Sponsor Name:Amsterdam University Medical Centers, location AMC | ||
Full Title: Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently? | ||
Medical condition: Ischemic diabetic foot ulcers | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-010968-42 | Sponsor Protocol Number: DGD-44-045 | Start Date*: 2009-07-07 | ||||||||||||||||
Sponsor Name:GUERBET | ||||||||||||||||||
Full Title: Efficacy evaluation of DOTAREM®-enhanced MRA compared to GADOVIST®–enhanced MRA in the diagnosis of clinically significant abdominal or lower limb arterial diseases | ||||||||||||||||||
Medical condition: Patient suffering from abdominal or lower limb arterial diseases | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) DE (Completed) ES (Completed) AT (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-000266-37 | Sponsor Protocol Number: Version7-20/12/2018 | Start Date*: 2019-06-21 |
Sponsor Name:Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal | ||
Full Title: Randomized clinical trial to evaluate the efficacy and safety of the treatment with supplementary oxygen in patients with Intermediate-Risk pulmonary embolism (PE) | ||
Medical condition: Acute symptomatic pulmonary embolism | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002547-66 | Sponsor Protocol Number: 308861 | Start Date*: 2005-11-28 | |||||||||||
Sponsor Name:Schering AG | |||||||||||||
Full Title: Intra-individual open-label multicenter comparison study of magnetic resonance angiography (MRA) with the blood pool contrast agent Vasovist® and a conventional extracellular contrast agent with in... | |||||||||||||
Medical condition: Patients who have aortoiliac disease Fontaine-stage IIb – IV and an indication for the evaluation of the infrarenal aorta and the peripheral run-off arteries (i.e. from infrarenal aorta to calves). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003832-24 | Sponsor Protocol Number: GE IDE No. E00605 | Start Date*: 2006-07-10 |
Sponsor Name:Deutsches Herzzentrum München | ||
Full Title: An open, prospective, randomized, comparative study to evaluate the effect of Iodixanol 320 compared to Iomeprol 350 on contrast medium induced nephropathy in patients with impaired renal function ... | ||
Medical condition: Patients with symptomatic coronary artery disease, impaired renal function (GFR<60ml/min) undergoing percutaneous coronary intervention | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-007175-24 | Sponsor Protocol Number: CRFB002AHU02T | Start Date*: 2009-02-06 | |||||||||||
Sponsor Name:University of Pécs, Medical School, Department of Ophthalmology | |||||||||||||
Full Title: A randomized, controlled, two-center phase II. study assessing the efficacy and safety of intravitreal Lucentis injections in patients with clinically significant macular edema secondary to central... | |||||||||||||
Medical condition: Macular edema secondary to central retinal vein occlusion | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001970-29 | Sponsor Protocol Number: SP777 | Start Date*: 2005-10-14 | |||||||||||
Sponsor Name:Schwarz Pharma Deutschland GmbH | |||||||||||||
Full Title: Multinational, prospective, randomized, double-blind, placebo-controlled, parallel groups study to assess the efficacy and safety of Prostaglandin E1 in subjects with circulatory disturbance of a limb | |||||||||||||
Medical condition: Peripheral arterial occlusive disease (PAOD) Fontaine stage IV | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001455-37 | Sponsor Protocol Number: 1331TMF | Start Date*: 2011-12-21 | |||||||||||
Sponsor Name:Department of Radiology, Oslo University Hospital, Norway | |||||||||||||
Full Title: Prospective randomized interventional study. Compare the effect of bleomycin and Tetradecyl Sodium Sulphate (Fibrovein) in the treatment of venous malformations. Clinical neurological and neurophys... | |||||||||||||
Medical condition: Venous malformation | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001250-91 | Sponsor Protocol Number: GV-002.001 | Start Date*: 2005-10-04 |
Sponsor Name:GenVec, Inc. | ||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of BIOBYPASS® (ADGVVEGF121.10NH) Delivered by NOGA-Guided/MYOSTAR Catheter in "No Option" Patients with Cla... | ||
Medical condition: Moderate to severe angina pectoris due to advanced coronary artery disease (CAD). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) AT (Completed) DE (Completed) GB (Completed) BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000394-21 | Sponsor Protocol Number: A6301094 | Start Date*: 2016-07-20 | |||||||||||
Sponsor Name:Pfizer Inc | |||||||||||||
Full Title: A THREE MONTH PROSPECTIVE OPEN LABEL STUDY OF THERAPY WITH FRAGMIN® (DALTEPARIN SODIUM INJECTION) IN CHILDREN WITH VENOUS THROMBOEMBOLISM WITH OR WITHOUT MALIGNANCIES. | |||||||||||||
Medical condition: Acute treatment and secondary prophylaxis of recurrent VTE (venous thromboembolism) in children with or without cancer. | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) SI (Completed) PL (Completed) GB (Completed) DE (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-013112-12 | Sponsor Protocol Number: REGENERATE/DCM/2.0 | Start Date*: 2010-04-22 | |||||||||||
Sponsor Name:Barts & the London NHS Trust | |||||||||||||
Full Title: Randomised Controlled Trial To Compare The effects of G-CSF(Granocyte™) And Autologous Bone Marrow Progenitor Cells On Quality Of Life And Left Ventricular Function In Patients with Idiopathic Dila... | |||||||||||||
Medical condition: Idiopathic Dilated Cardiomyopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004068-21 | Sponsor Protocol Number: PADHIF00805 | Start Date*: 2006-01-11 |
Sponsor Name:Genzyme Europe BV | ||
Full Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study of Ad2/Hypoxia Inducible Factor (HIF)-1alfa/VP16 Administered by Intramuscular Injection to Patients with ... | ||
Medical condition: Peripheral Arterial Disease (PAD) with no or poor Chronic Critical Limb Ischemia (CLI) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-018235-17 | Sponsor Protocol Number: 0709 | Start Date*: 2010-04-16 | |||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||
Full Title: TAILOR Trombocytes And IndividuaLization of ORal antiplatelet treatment after percutaneous coronary intervention (Trombocytter og individualiseret oral antitrombotisk behandling efter perkutan koro... | |||||||||||||
Medical condition: Patientens undergoing elective, subacute or acute percutaneous coronary intervention (PI) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000239-34 | Sponsor Protocol Number: PONTIACII | Start Date*: 2015-12-30 |
Sponsor Name:Medizinische Universität Wien | ||
Full Title: NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease; a prospective randomized trial | ||
Medical condition: The purpose of this study is to evaluate the effect of high dose Renin-Angiotensin System (RAS)-antagonists and beta-blocker treatment for the primary prevention of cardiac events in a population o... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) NL (Ongoing) GB (GB - no longer in EU/EEA) ES (Ongoing) HU (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000097-26 | Sponsor Protocol Number: TDE-PH-310 | Start Date*: 2012-11-06 | |||||||||||
Sponsor Name:United Therapeutics Corporation | |||||||||||||
Full Title: A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects with Pulmonary Arterial Hypertension Receiving Background Oral... | |||||||||||||
Medical condition: Pulmonary Arterial Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) AT (Completed) NL (Completed) IT (Completed) SE (Completed) BE (Completed) DK (Completed) GR (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000801-50 | Sponsor Protocol Number: TDE-PH-302 | Start Date*: 2007-02-19 | |||||||||||
Sponsor Name:United Therapeutics Corporation | |||||||||||||
Full Title: A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects with Pulmonary Arteria... | |||||||||||||
Medical condition: Idiopathic or Familial pulmonary arterial hypertension (PAH), including PAH associated with: 1) Appetite suppressant/toxin use, or 2) Repaired congenital systemic-to-pulmonary shunts (repaired ≥... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) FR (Completed) BE (Completed) NL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002508-13 | Sponsor Protocol Number: PADHIF00704 | Start Date*: 2005-04-13 | |||||||||||
Sponsor Name:Genzyme Europe BV | |||||||||||||
Full Title: A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Dose-Selection Study of Ad2/Hypoxia Inducible Factor HIF-1alfa/VP16 in Patients with Intermittent Claudication. | |||||||||||||
Medical condition: Peripheral Arterial Disease (PAD): Intermittent Claudication (IC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000800-17 | Sponsor Protocol Number: TDE-PH-301 | Start Date*: 2007-02-15 | |||||||||||
Sponsor Name:United Therapeutics Corporation | |||||||||||||
Full Title: A 16-Week International, Multicenter, Double-Blind, Randomized, Placebo Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Combination with an Endothelin... | |||||||||||||
Medical condition: Idiopathic or Familial pulmonary arterial hypertension (PAH), including PAH associated with: 1) Appetite suppressant use, or 2) Repaired congenital systemic-to-pulmonary shunts (repaired ≥ 5 yea... | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) GB (Completed) NL (Completed) AT (Completed) FR (Completed) BE (Completed) IT (Completed) DE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004631-31 | Sponsor Protocol Number: REM-PH-416 | Start Date*: 2012-03-13 | |||||||||||||||||||||
Sponsor Name:United Therapeutics Corp. | |||||||||||||||||||||||
Full Title: A 16 Week, Open Label, Multi-Centre, Study to Evaluate the Safety, Tolerability and Pharmacodynamic Effects of a Rapid Dose Titration Regimen of Subcutaneous Remodulin® Therapy in Subjects with Pul... | |||||||||||||||||||||||
Medical condition: Pulmonary Arterial Hypertension (PAH) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-005375-14 | Sponsor Protocol Number: TS-104 | Start Date*: 2013-06-03 | ||||||||||||||||
Sponsor Name:Biocompatibles UK Ltd | ||||||||||||||||||
Full Title: A prospective randomized clinical trial on 90Yttrium trans-arterial radio-Embolization (Therasphere) vs. standard of care (sorafenib) for the treatment of advanced Hepatocellular carcinoma (HCC) ... | ||||||||||||||||||
Medical condition: Advanced Hepatocellular Carcinoma (HCC) with Portal Vein Thrombosis (PVT) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) GB (Prematurely Ended) ES (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.